<bill session="108" type="s" number="722" updated="2023-01-15T23:03:26Z">
  <state datetime="2003-03-26">REFERRED</state>
  <status>
    <introduced datetime="2003-03-26"/>
  </status>
  <introduced datetime="2003-03-26"/>
  <titles>
    <title type="display">Dietary Supplement Safety Act of 2003</title>
    <title type="official" as="introduced">A bill to amend the Federal Food, Drug, and Cosmetic Act to require that manufacturers of dietary supplements submit to the Food and Drug Administration reports on adverse experiences with dietary supplements, and for other purposes.</title>
    <title type="short" as="introduced">Dietary Supplement Safety Act of 2003</title>
  </titles>
  <sponsor bioguide_id="D000563"/>
  <cosponsors>
    <cosponsor bioguide_id="C001041" joined="2003-07-10"/>
    <cosponsor bioguide_id="F000062" joined="2003-07-10"/>
    <cosponsor bioguide_id="M000303" joined="2003-11-04"/>
    <cosponsor bioguide_id="S000148" joined="2003-04-02"/>
  </cosponsors>
  <actions>
    <action datetime="2003-03-26">
      <text>Introduced in Senate</text>
    </action>
    <action datetime="2003-03-26" state="REFERRED">
      <text>Read twice and referred to the Committee on Health, Education, Labor, and Pensions.</text>
    </action>
    <action datetime="2004-04-01">
      <text>Sponsor introductory remarks on measure.</text>
      <reference ref="CR S3547-3548"/>
    </action>
  </actions>
  <committees>
    <committee code="SSHR" name="Senate Health, Education, Labor, and Pensions" subcommittee="" activity="Referral"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Agriculture and food"/>
    <term name="Administrative procedure"/>
    <term name="Business records"/>
    <term name="Clinical trials"/>
    <term name="Commerce"/>
    <term name="Communication in medicine"/>
    <term name="Consumer protection"/>
    <term name="Data banks"/>
    <term name="Department of Health and Human Services"/>
    <term name="Dietary supplements"/>
    <term name="Drug interactions"/>
    <term name="Economics and Public Finance"/>
    <term name="Food industry"/>
    <term name="Food safety"/>
    <term name="Government Operations and Politics"/>
    <term name="Government paperwork"/>
    <term name="Health"/>
    <term name="Health information systems"/>
    <term name="Labeling"/>
    <term name="Law"/>
    <term name="Manufacturing industries"/>
    <term name="Marketing"/>
    <term name="Medical research"/>
    <term name="Public health"/>
    <term name="Science, Technology, Communications"/>
    <term name="Small business"/>
    <term name="Steroids"/>
  </subjects>
  <amendments/>
  <summary date="2006-11-28T17:35:40Z" status="Introduced in Senate">Amends the Federal Food, Drug, and Cosmetic Act to require each manufacturer of a dietary supplement (supplement), and each packer or distributor of a supplement the name of which appears on the labeling, to report serious adverse experiences to the Secretary of Health and Human Services and to investigate such occurrences. Defines a serious adverse experience as an adverse event associated with the use of a supplement in a human that involves death or one of other serious calamities. Directs the Secretary to conduct a clinical evaluation of each such reported experience.Requires the manufacturer of a dietary supplement to report periodically on other adverse experiences and to review such occurrences.Allows the Secretary to grant a waiver from the above reporting, reviewing, and investigating requirements with respect to a dietary supplement upon determination that compliance is not necessary to protect the public health.Authorizes the Secretary to require a manufacturer to conduct postmarket surveillance for a supplement under specified circumstances.Permits the Secretary to require a manufacturer of a supplement or of an ingredient in a supplement to demonstrate that its product is safe under specified circumstances. Directs the Secretary to approve the continued marketing of such a supplement or ingredient or to disapprove it.Prohibits any introduction into interstate commerce of a supplement containing a stimulant unless it is approved by the Secretary under this Act.Amends the Act to exclude a product that bears or contains an anabolic steroid from the definition of a dietary supplement for a specified chapter of the Act.Eliminates a provision of the Act requiring the United States to bear the burden of proof to show a supplement or an ingredient in a supplement is adulterated due to a safety violation.</summary>
</bill>
